United States Immunotherapy Drugs Market Report 2016

United States Immunotherapy Drugs Market Report 2016

1 Immunotherapy Drugs Overview

1.1 Product Overview and Scope of Immunotherapy Drugs

1.2 Classification of Immunotherapy Drugs

1.2.1 Specific Cancer Immunotherapy Drugs

1.2.2 Non-Specific Cancer Immunotherapy Drugs

1.2.3 Type III

1.3 Application of Immunotherapy Drugs

1.3.1 Leukemia Treatment

1.3.2 Colorectal Cancer Treatment

1.3.3 Other Cancer Treatment

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Immunotherapy Drugs (2011-2021)

1.4.1 United States Immunotherapy Drugs Sales and Growth Rate (2011-2021)

1.4.2 United States Immunotherapy Drugs Revenue and Growth Rate (2011-2021)

2 United States Immunotherapy Drugs Competition by Manufacturers

2.1 United States Immunotherapy Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Immunotherapy Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Immunotherapy Drugs Average Price by Manufactures (2015 and 2016)

2.4 Immunotherapy Drugs Market Competitive Situation and Trends

2.4.1 Immunotherapy Drugs Market Concentration Rate

2.4.2 Immunotherapy Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Immunotherapy Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Immunotherapy Drugs Sales and Market Share by Type (2011-2016)

3.2 United States Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)

3.3 United States Immunotherapy Drugs Price by Type (2011-2016)

3.4 United States Immunotherapy Drugs Sales Growth Rate by Type (2011-2016)

4 United States Immunotherapy Drugs Sales (Volume) by Application (2011-2016)

4.1 United States Immunotherapy Drugs Sales and Market Share by Application (2011-2016)

4.2 United States Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Immunotherapy Drugs Manufacturers Profiles/Analysis

5.1 Merck-Pfizer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Immunotherapy Drugs Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Merck-Pfizer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Eli Lilly

5.2.2 Immunotherapy Drugs Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Eli Lilly Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Amgen

5.3.2 Immunotherapy Drugs Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Amgen Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Roche

5.4.2 Immunotherapy Drugs Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Roche Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bristol Myers Squibb

5.5.2 Immunotherapy Drugs Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bristol Myers Squibb Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Dendreon (Valeant)

5.6.2 Immunotherapy Drugs Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Dendreon (Valeant) Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Novartis

5.7.2 Immunotherapy Drugs Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Novartis Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Seattle Genetics

5.8.2 Immunotherapy Drugs Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Seattle Genetics Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Celgene

5.9.2 Immunotherapy Drugs Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Celgene Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 AstraZeneca

5.10.2 Immunotherapy Drugs Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 AstraZeneca Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Northwest Biotherapeutics

6 Immunotherapy Drugs Manufacturing Cost Analysis

6.1 Immunotherapy Drugs Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Immunotherapy Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Immunotherapy Drugs Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Immunotherapy Drugs Market Forecast (2016-2021)

10.1 United States Immunotherapy Drugs Sales, Revenue Forecast (2016-2021)

10.2 United States Immunotherapy Drugs Sales Forecast by Type (2016-2021)

10.3 United States Immunotherapy Drugs Sales Forecast by Application (2016-2021)

10.4 Immunotherapy Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Immunotherapy Drugs

Table Classification of Immunotherapy Drugs

Figure United States Sales Market Share of Immunotherapy Drugs by Type in 2015

Figure Specific Cancer Immunotherapy Drugs Picture

Figure Non-Specific Cancer Immunotherapy Drugs Picture

Table Application of Immunotherapy Drugs

Figure United States Sales Market Share of Immunotherapy Drugs by Application in 2015

Figure Leukemia Treatment Examples

Figure Colorectal Cancer Treatment Examples

Figure Other Cancer Treatment Examples

Figure United States Immunotherapy Drugs Sales and Growth Rate (2011-2021)

Figure United States Immunotherapy Drugs Revenue and Growth Rate (2011-2021)

Table United States Immunotherapy Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Immunotherapy Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Immunotherapy Drugs Sales Share by Manufacturers

Figure 2016 Immunotherapy Drugs Sales Share by Manufacturers

Table United States Immunotherapy Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Immunotherapy Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Immunotherapy Drugs Revenue Share by Manufacturers

Table 2016 United States Immunotherapy Drugs Revenue Share by Manufacturers

Table United States Market Immunotherapy Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Immunotherapy Drugs Average Price of Key Manufacturers in 2015

Figure Immunotherapy Drugs Market Share of Top 3 Manufacturers

Figure Immunotherapy Drugs Market Share of Top 5 Manufacturers

Table United States Immunotherapy Drugs Sales by Type (2011-2016)

Table United States Immunotherapy Drugs Sales Share by Type (2011-2016)

Figure United States Immunotherapy Drugs Sales Market Share by Type in 2015

Table United States Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)

Table United States Immunotherapy Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Immunotherapy Drugs by Type (2011-2016)

Table United States Immunotherapy Drugs Price by Type (2011-2016)

Figure United States Immunotherapy Drugs Sales Growth Rate by Type (2011-2016)

Table United States Immunotherapy Drugs Sales by Application (2011-2016)

Table United States Immunotherapy Drugs Sales Market Share by Application (2011-2016)

Figure United States Immunotherapy Drugs Sales Market Share by Application in 2015

Table United States Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)

Figure United States Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)

Table Merck-Pfizer Basic Information List

Table Merck-Pfizer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Merck-Pfizer Immunotherapy Drugs Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Immunotherapy Drugs Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Immunotherapy Drugs Sales Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Immunotherapy Drugs Sales Market Share (2011-2016)

Table Bristol Myers Squibb Basic Information List

Table Bristol Myers Squibb Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol Myers Squibb Immunotherapy Drugs Sales Market Share (2011-2016)

Table Dendreon (Valeant) Basic Information List

Table Dendreon (Valeant) Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dendreon (Valeant) Immunotherapy Drugs Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Immunotherapy Drugs Sales Market Share (2011-2016)

Table Seattle Genetics Basic Information List

Table Seattle Genetics Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Seattle Genetics Immunotherapy Drugs Sales Market Share (2011-2016)

Table Celgene Basic Information List

Table Celgene Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celgene Immunotherapy Drugs Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Immunotherapy Drugs Sales Market Share (2011-2016)

Table Northwest Biotherapeutics Basic Information List

Table Northwest Biotherapeutics Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Northwest Biotherapeutics Immunotherapy Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Immunotherapy Drugs

Figure Manufacturing Process Analysis of Immunotherapy Drugs

Figure Immunotherapy Drugs Industrial Chain Analysis

Table Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2015

Table Major Buyers of Immunotherapy Drugs

Table Distributors/Traders List

Figure United States Immunotherapy Drugs Production and Growth Rate Forecast (2016-2021)

Figure United States Immunotherapy Drugs Revenue and Growth Rate Forecast (2016-2021)

Table United States Immunotherapy Drugs Production Forecast by Type (2016-2021)

Table United States Immunotherapy Drugs Consumption Forecast by Application (2016-2021)